通过植入式压力传感器遥测眼压——ARGOS-02试验的12个月结果
这项前瞻性、非对照、开放标签、多中心临床研究在22例计划行白内障手术的原发性开角型青光眼患者中,于人工晶状体植入后单次手术植入环状、睫状沟放置的可折叠眼压传感器。12个月随访显示植入安全、无意外器械相关不良事件,传感器测压与Goldmann压平眼压计一致性良好(ICC(3,k)=0.783,95%CI:0.743,0.817),传感器读数平均高3.2 mm Hg(95%CI:2.8,3.5 mm Hg)。
要点
- 22例原发性开角型青光眼患者植入EYEMATE-IO传感器,手术并发症少,无意外器械相关不良事件。
- EYEMATE-IO与Goldmann压平眼压计一致性良好,ICC(3,k)=0.783(95%CI:0.743,0.817)。
- EYEMATE-IO测值高于Goldmann压平眼压计,平均差异3.2 mm Hg(95%CI:2.8,3.5 mm Hg)。
核心结论
- EYEMATE-IO传感器在22例患者中安全植入,并在随访至结束时表现可靠,该器械可实现对眼压的持续和长期测量。
研究设计与样本
- 前瞻性、非对照、开放标签、多中心临床研究。
- 研究对象为定期安排白内障手术的原发性开角型青光眼患者。
- 在人工晶状体植入后单次手术植入环状、睫状沟放置的可折叠眼压传感器。
- 随访12个月,记录手术并发症及不良事件。
主要发现
- EYEMATE-IO植入物在22例患者中成功植入,手术并发症少,无意外器械相关不良事件。
- 所有眼部不良事件在适当治疗下迅速缓解。
- EYEMATE-IO与Goldmann压平眼压计比较测量一致性良好,ICC(3,k)=0.783(95%CI:0.743,0.817)。
- EYEMATE-IO测值高于Goldmann压平眼压计,平均差异3.2 mm Hg(95%CI:2.8,3.5 mm Hg)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The aim of this study was to investigate the safety and performance of the second generation of an implantable intraocular pressure (IOP) sensor in patients with primary open angle glaucoma (POAG). DESIGN: prospective, noncomparative, open-label, multicenter clinical investigation. METHODS: In this study, patients with POAG, regularly scheduled for cataract surgery, were implanted with a ring-shaped, sulcus-placed, foldable IOP sensor in a single procedure after intraocular lens implantation. Surgical complications as well as adverse events (AEs) during 12 months of follow-up were recorded. At each follow-up visit, a complete ophthalmic examination, including visual acuity, IOP, slit lamp examination, and dilated funduscopy as well as comparative measurements between Goldmann applanation tonometry and the EYEMATE-IO implant were performed. RESULTS: The EYEMATE-IO implant was successfully implanted in 22 patients with few surgical complications and no unexpected device-related AEs. All ocular AEs resolved quickly under appropriate treatment. Comparative measurements showed good agreement between EYEMATE-IO and Goldmann applanation tonometry (GAT) with an intraclass correlation coefficient (ICC(3,k)) of 0.783 (95% confidence interval [CI]: 0.743, 0.817). EYEMATE-IO measurements were higher than GAT, with a mean difference of 3.2 mm Hg (95% CI: 2.8, 3.5 mm Hg). CONCLUSIONS: The EYEMATE-IO sensor was safely implanted in 22 patients and performed reliably until the end of follow-up. This device allows for continual and long-term measurements of IOP.
引用
- Choritz L, Mansouri K, van den Bosch J, et al. Telemetric Measurement of Intraocular Pressure via an Implantable Pressure Sensor-12-Month Results from the ARGOS-02 Trial. Am J Ophthalmol. 2019. PMID: 31545953. doi:10.1016/j.ajo.2019.09.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。